0000904454-05-000054.txt : 20120705 0000904454-05-000054.hdr.sgml : 20120704 20050127144039 ACCESSION NUMBER: 0000904454-05-000054 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050127 DATE AS OF CHANGE: 20050127 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001235010 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043561634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-79927 FILM NUMBER: 05553412 BUSINESS ADDRESS: STREET 1: 43 MOULTON STREET CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 6174919700 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MVM International Life Sciences Fund No 1 L P CENTRAL INDEX KEY: 0001296587 IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 6 HENRIETTA STREET CITY: LONDON STATE: X0 ZIP: WC2E8PIU BUSINESS PHONE: 44-2075577517 MAIL ADDRESS: STREET 1: 6 HENRIETTA STREET CITY: LONDON STATE: X0 ZIP: WC2E8PIU SC 13G 1 s13g_0126-2005momenta.txt SCHEDULE 13G CUSIP No. 60877T 10 1 Page 1 of 9 Pages SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 --------------------- SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILES PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. )(1) Momenta Pharmaceuticals, Inc. -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.0001 par value -------------------------------------------------------------------------------- (Title of Class of Securities) 60877T 10 1 -------------------------------------------------------------------------------- June 25, 2004 -------------------------------------------------------------------------------- Date of Event Which Requires Filing of this Statement Check the appropriate box to designate the rule pursuant to which this Schedule is Filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) ----------------------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. CUSIP No. 60877T 10 1 Page 2 of 9 Pages -------------------------------------------------------------------------------- 1) Name of Reporting Person MVM Limited I.R.S. Identification No. of Above Person (Entities Only) -------------------------------------------------------------------------------- 2) Check the Appropriate Box (a) [X] if a Member of a Group (b) [ ] -------------------------------------------------------------------------------- 3) SEC Use Only -------------------------------------------------------------------------------- 4) Citizenship or Place United Kingdom of Organization -------------------------------------------------------------------------------- Number of 5) Sole Voting Shares Beneficially Power -0- Owned by Each Reporting Person With ---------------------------------------- 6) Shared Voting Power 8,656 shares of Common Stock ---------------------------------------- 7) Sole Disposi- tive Power -0- ---------------------------------------- 8) Shared Dis- positive Power 8,656 shares of Common Stock ---------------------------------------- 9) Aggregate Amount Beneficially 8,656 shares Owned by Each Reporting person of Common Stock -------------------------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares -------------------------------------------------------------------------------- 11) Percent of Class Represented by less than 0.1% Amount in Row (9) -------------------------------------------------------------------------------- 12) Type of Reporting Person 00 -2- CUSIP No. 60877T 10 1 Page 3 of 9 Page -------------------------------------------------------------------------------- 1) Name of Reporting Person MVM International Life I.R.S. Identification Sciences Fund No. 1, L.P. No. of Above Person (Entities Only) -------------------------------------------------------------------------------- 2) Check the Appropriate Box (a) [X] if a Member of a Group (b) [ ] -------------------------------------------------------------------------------- 3) SEC Use Only -------------------------------------------------------------------------------- 4) Citizenship or Place United Kingdom of Organization -------------------------------------------------------------------------------- Number of 5) Sole Voting Shares Beneficially Power -0- Owned by Each Reporting Person With ---------------------------------------- 6) Shared Voting 2,684,748 shares Power of Common Stock ---------------------------------------- 7) Sole Disposi- tive Power -0- ---------------------------------------- 8) Shared Dis- 2,684,748 shares positive Power of Common Stock ---------------------------------------- 9) Aggregate Amount Beneficially 2,684,748 shares Owned by Each Reporting person of Common Stock -------------------------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares -------------------------------------------------------------------------------- 11) Percent of Class Represented by 10.6% Amount in Row (9) -------------------------------------------------------------------------------- 12) Type of Reporting Person PN -3- CUSIP No. 60877T 10 1 Page 4 of 9 Page -------------------------------------------------------------------------------- Schedule 13G ------------ Item 1(a) - Name of Issuer: Momenta Pharmaceuticals, Inc. Item 1(b) - Address of Issuer's Principal Executive Offices: 675 West Kendall Street Cambridge, MA 02142 Item 2(a) - Name of Person Filing: MVM Limited ("MVM") MVM International Life Sciences Fund No. 1, L.P. ("MVM Fund No. 1") Item 2(b) - Address of Principal Business Office: 6 Henrietta Street London WC2E 8 PU United Kingdom Item 2(c) - Place of Organization: United Kingdom Item 2(d) - Title of Class of Securities: Common Stock, $.0001 par value Item 2(e) - CUSIP Number: 60877T 10 0 Item 3 - Statements Filed Pursuant to Rules 13d-1(b) or 13d-2(b): Not applicable. -4- CUSIP No. 60877T 10 1 Page 5 of 9 Page Item 4 - Ownership. (a) Amount Beneficially Owned: MVM: 8,656 shares of Common Stock MVM Fund No. 1: 2,684,748 shares of Common Stock (b) Percent of Class: MVM: less than 0.1% MVM Fund No. 1: 10.6% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: -0- (ii) shared power to vote or to direct the vote: MVM: 8,656 shares of Common Stock MVM Fund No. 1: 2,684,748 shares of Common Stock (iii) sole power to dispose or to direct the disposition of: -0- (iv) shared power to dispose or to direct the disposition of: MVM: 8,656 shares of Common Stock MVM Fund No. 1: 2,684,748 shares of Common Stock Item 5 - Ownership of Five Percent or Less of a Class: Not applicable. Item 6 - Ownership of More than Five Percent on Behalf of Another Person: Not applicable. Item 7 - Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Company: Not applicable. Item 8 - Identification and Classification of Members of the Group: See Exhibit 2. -5- CUSIP No. 60877T 10 1 Page 6 of 9 Page Item 9 - Notice of Dissolution of Group: Not applicable. Item 10 - Certification: Not applicable. -6- CUSIP No. 60877T 10 1 Page 7 of 9 Page Signature: After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. MVM LIMITED By /s/ Thomas Casdagli ----------------------------- Director of Finance MVM INTERNATIONAL LIFE SCIENCES FUND NO. 1, L.P. By /s/ Thomas Casdagli ----------------------------- Director of Finance Date: January 26, 2005 -7- CUSIP No. 60877T 10 1 Page 8 of 9 Page EXHIBIT 1 AGREEMENT OF MVM LIMITED AND MVM INTERNATIONAL LIFE SCIENCES FUND NO. 1, L.P. PURSUANT TO RULE 13d-1(f) ------------------------- The undersigned hereby agree that the Information Statement on Schedule 13G to which this Agreement is annexed as Exhibit 1 is filed on behalf of each of them in accordance with provisions of 13d-1(f) under the Securities Exchange Act of 1934, as amended. MVM LIMITED By /s/ Thomas Casdagli ----------------------------- Director of Finance MVM INTERNATIONAL LIFE SCIENCES FUND NO. 1, L.P. By /s/ Thomas Casdagli ----------------------------- Director of Finance Date: January 26, 2005 -8- CUSIP No. 60877T 10 1 Page 9 of 9 Page EXHIBIT 2 Identification and Classification of Members of the Group --------------------------------- MVM Limited and MVM International Life Sciences Fund No. 1, L.P. are filing this statement on Schedule 13G as a group. MVM Limited is a company organized in the United Kingdom. MVM International Life Sciences Fund No. 1, L.P. is a United Kingdom limited partnership. MVM Limited is the discretionary investment manager of MVM International Life Sciences Fund No. 1, L.P. -9-